STAT3 and lung cancer: BP-1-102, an analog of S3I-201, inhibits STAT3 through the same mechanism by binding to the SH2 domain and selectively suppresses malignant cell growth, survival, transformation, migration, and invasion in human breast and lung cancer cells [147].